Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:developedBy |
Brilacidin
Kevetrin |
| gptkbp:focusesOn |
antibiotics
oncology dermatology |
| gptkbp:foundedBy |
Dr. Krishna Menon
Leo Ehrlich |
| gptkbp:foundedIn |
2007
|
| gptkbp:headquartersLocation |
gptkb:Beverly,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cellceutix Corporation
|
| gptkbp:renamed |
Innovation Pharmaceuticals Inc.
|
| gptkbp:tradedOn |
OTCQB: CTIX
|
| gptkbp:website |
http://www.cellceutix.com/
|
| gptkbp:bfsParent |
gptkb:CTIX
|
| gptkbp:bfsLayer |
8
|